BIOMAT Database Logo BIOMAT Database Logo

Drug-resistant tuberculosis in New York City. 1993

I Joffe

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

I Joffe
Drug-resistant tuberculosis in New York City.
July 1993, The New England journal of medicine,
I Joffe
Drug-resistant tuberculosis in New York City.
July 1993, The New England journal of medicine,
I Joffe
The emergence of drug-resistant tuberculosis in New York City.
February 1993, The New England journal of medicine,
I Joffe
Drug-resistant tuberculosis in New York City: lessons to remember.
June 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
I Joffe
Drug resistant tuberculosis among the homeless in New York City.
July 1990, New York state journal of medicine,
I Joffe
Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
June 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
I Joffe
A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
March 1997, Archives of internal medicine,
I Joffe
Emergence of fluoroquinolone-resistant tuberculosis in New York City.
May 1995, Lancet (London, England),
I Joffe
Tuberculosis in New York City.
January 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
I Joffe
The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City.
June 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!